Analysis of animal models based on pre-clinical symptoms of gout
Abstract
Gout is a type of arthritis, which is a group of related disorders caused by episodes of abnormal inflammation in the joints. It is a metabolic disease characterized by high levels of uric acid in the blood. Uric acid is the end product of purine metabolism and hyperuricemia is caused by abnormalities of purine metabolism. Hyperuricemia is a risk factor for gout, heart disease, high blood pressure (hypertension), diabetes, and acute and chronic kidney disease. This research may attract widespread interest to researchers focusing on the different types of crystalline arthritis. There are over 100 types of arthritis. The most common forms are osteoarthritis (degenerative joint disease), rheumatoid arthritis, gout and pseudo-gout, septic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, still's disease etc.
Many animal models are available to get rid of gout, mainly the hyperuricemia animal model, monosodium urate air pouch gout model, Intra-articular gout in rat, Paw edema, Gouty Arthritis Model, and Gouty nephropathy model. Various investigations have created a reliable and economical animal model for arthritis in a relatively short brief timeframe, manifested by long-term gross and behavioral abnormalities along with intra-articular monosodium urate deposition and tophi formation.
Lately years, hyperuricemia disease has gradually increased in the world. There are many updates that can be made by taking the arthritis model. If such a situation prevails, then in a few years, the patients of gout can increase in great quantity and there is some treatment for this disease. In any case, further review is really needed to focus on its particular pathogenesis and drugs.
Keywords: Gout, Arthritis, Gout Animal Model, Inflammation, Hyperuricemia, monosodium urate, crystalline arthritis.
Keywords:
Gout, Arthritis, Gout Animal Model, Inflammation, Hyperuricemia, monosodium urate, crystalline arthritisDOI
https://doi.org/10.22270/jddt.v12i1.5270References
Kang L, Miao MS, Liu HJ and Li N. Analysis of animal models based on clinical symptoms of gout. Zhongguo Zhongyao Zazhi. 2018; 43 (22):4547 - 4552.
Guan J, Huang XQ, Dong J Le, Lu HM, Lin YW, Liu M, Yi ZB, Wu LM, Huang YM and Lan T. A novel mouse model of hyperuricemia and gouty nephropathy. Chinese Medical Journal. 2020; 133(16):2012-2014. https://doi.org/10.1097/CM9.0000000000000964
Zhou M, Ze K, Hua L, Liu L, Kuai L, Zhang M, Li B, Wang Y and Li X. Cyr61 Promotes Inflammation of a Gouty Arthritis Model in Rats. Mediators Inflammation. 2020; 2020:1-13. https://doi.org/10.1155/2020/8298615
Zhu Y, Peng X and Ling G. An update on the animal models in hyperuricemia research. Clinical and experimental rheumatology. 2017; 35(5):860-864.
Gonzalez EB. An update on the pathology and clinical management of gouty arthritis. Clinical Rheumatol. 2012; 31(1):13-21. https://doi.org/10.1007/s10067-011-1877-0
Han J, Xie Y, Sui F, Liu C, Du X, Liu C, Fengx, Jiang D and Shenqi Z. decoction ameliorates monosodium urate crystal-induced gouty arthritis in rats through anti-inflammatory and anti-oxidative effects. Molecular Medicine Reports. 2016; 14(3):2589-2597. https://doi.org/10.3892/mmr.2016.5526
Hong F, Zheng A, Xu P, Wang J, Xue T, Dai S, Pan S, Guo Y, Xie X, Li L, Qiao X, Liu G and Zhai Y. High-protein diet induces hyperuricemia in a new animal model for studying human gout. International Journal of Molecular Sciences. 2020; 21(6):1 https://doi.org/10.3390/ijms21062147
Wu X, Wakamiya M, Vaishnav S, Geske R, Montgomery C, Jones P, Bradley A and Caskey T. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proceedings of the National Academy of Sciences. 1994; 91(2):742-746. https://doi.org/10.1073/pnas.91.2.742
Mandal AK and Mount DB. The molecular physiology of uric acid homeostasis. Annu. Rev. Physiol. 2015, 77:323-345. https://doi.org/10.1146/annurev-physiol-021113-170343
Fellstrom B, Danielson BG, Karlstrom B, Lithell H, Ljunghall, S and Vessby B. The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease. Clin. Sci. 1983, 64:399-405. https://doi.org/10.1042/cs0640399
Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A and Herrero-Beites AM. Renal under excretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 2002, 47:610-613. https://doi.org/10.1002/art.10792
Kuo CF, Grainge MJ, Zhang W and Doherty M. Global epidemiology of gout: Prevalence, incidence and risk factors. Nat. Rev. Rheumatol. 2015, 11:649-662. https://doi.org/10.1038/nrrheum.2015.91
Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL and Janssens HJ. Gout classification criteria: American College of Rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 2015, 74:1789-1798. https://doi.org/10.1136/annrheumdis-2015-208237
Martinon F, Petrilli V, Mayor A, Tardivel A and Tschopp J. Gout associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440:237-241. https://doi.org/10.1038/nature04516
Anand PK and Kanneganti TD. NLRP6 in infection and inflammation. Microbes Infect. 2013; 15: 661-668. https://doi.org/10.1016/j.micinf.2013.06.009
Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. American Journal of Kidney Dis. 2002; 40(1):37-42. https://doi.org/10.1053/ajkd.2002.33911
Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Annals of Internal Medicine. 2005; 143(7):499-516. https://doi.org/10.7326/0003-4819-143-7-200510040-00009
Makarov SS, "NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction," Arthritis Research. 2001; 3(4)200-206. https://doi.org/10.1186/ar300
Kingsbury SR, Conaghan PG, and McDermott MF. "The role of the NLRP3 inflammasome in gout," Journal of Inflammation Research. 2011; 4:39-49. https://doi.org/10.2147/JIR.S11330
Hille R. "Molybdenum-containing hydroxylases". Archives of Biochemistry and Biophysics. 2005; 433(1):107-116. https://doi.org/10.1016/j.abb.2004.08.012
Singh D, Kumar V, and Singh C, "IFN- regulates xanthine oxidase-mediated iNOS-independent oxidative stress in maneb- and paraquat-treated rat polymorphonuclear leukocytes," Molecular and Cellular Biochemistry. 2017; 427(12):133-143. https://doi.org/10.1007/s11010-016-2905-9
Amat N, Umar A, Hoxur P, Anaydulla M, Imam G, Aziz R, Upur H, Kijjoa A & Moore N. "Traditional Uighur Medicine Karapxa decoction, inhibits liver xanthine oxidase and reduces serum uric acid concentrations in hyperuricemic mice and scavenges free radicals in vitro." BMC Complementary and Alternative Medicine. 2015; 15(1):131. https://doi.org/10.1186/s12906-015-0644-1
Lopez-Alarc C and Denicola A. "Evaluating the antioxidant capacity of natural products: a review on chemical and cellularbased assays," Analytica Chimica Acta. 2013; 763:1-10. https://doi.org/10.1016/j.aca.2012.11.051
Published
Abstract Display: 631 
PDF Downloads: 887 PDF Downloads: 214 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.